BNET Industries
Last Fiscal Year Sales:$9.7M
- Public
- US
Dow Jones Description
Renovis , Inc. is a science-driven, biopharmaceutical company that seeks to discover, develop and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases. Renovis applies its integrated capabilities in preclinical research and development, including molecular biology, medicinal chemistry, in vitro and in vivo pharmacology, drug metabolism and pharmacokinetics, toxicology and informatics, to identify and select small molecule drug candidates that meet stringent standards for development.
President
Michael KellyNumber of Employees 67
Contact Information
2 Corporate Dr
South San Francisco, California 94080-7047
(650) 266-1400
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
News & Analysis
Filter by
renovis inc. - All News and Analysis
STOCK ALERT Newsletter Reports Alerting Renovis, Inc.
M2 PRESSWIRE-11 April 2007-StockHeadquarters.com: STOCK ALERT Newsletter Reports Alerting Renovis, Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:11042007 StockHeadquarters.com reports alerting Renovis, Inc. (Nasdaq: RNVS) to its subscribers on April 10th in premarket after Renovis announced an agreement with Pfizer Inc. (NYSE: PFE)...
Pfizer plans to file for FDA approval on Sutent and Nabi Biopharmaceuticals initiates phase i study.
M2 PRESSWIRE-22 July 2005-US Financial Network: Pfizer plans to file for FDA approval on Sutent and Nabi Biopharmaceuticals initiates phase i studyC1994-2005 M2 COMMUNICATIONS LTD RDATE:22072005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU)....
Stocks on the Rise.
M2 PRESSWIRE-24 May 2005-WallStreetGrapevine: Stocks on the RiseC1994-2005 M2 COMMUNICATIONS LTD RDATE:24052005 Wall Street, NYC--Today, wallstreetgrapevine.com, named; Bio-Matrix Scientific Group Inc. (Pink Sheets: BMXG), Home Solutions Health Inc. (Pink Sheets: HSHL), Hi-Tech Pharmacal Co. Inc. (Nasdaq NM: HITK), and Renovis...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Michael Kelly | President |
| Jeffrey S Farrow | V.P., Finance and Cao |
| John C. Doyle | Senior Vice President, Corporate Development, and Chief Financial Officer |
| Tito Serafini | Vice President, Discovery Res & Chief Discovery Scientist |
| Donald Joseph | General Counsel & Senior Vice President, Corp Development |
| F. Jacob Huff | Vice President, Clinical Development |
| Jacob Huff | Vice President, Clinical Development |
| Edward E. Penhoet | Co-Founder |
| Judith A. Hemberger | Founder of Pharmion |
| Marc Tessier-Lavigne | Co-founder |
| Dr Robert C Malenka | |
| Edward M. Scolnick | |
| Farah Champsi | |
| Wade Smith |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Yasunori Kaneko | Board of Directors |
| John Friedman | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | President | Current |
| Evotech, Inc. | President, Renovis, Inc. and Member of the Senior Management | Current |
| Amgen Inc. | Vice President, Corporate Planning and Control | Current |
| Soho San Diego | Webmaster | Current |
| Routes Into Languages | Specialist | Current |
| University of Southampton | Head | Current |
| Soho San Diego | Board of Directors | Current |
| Languages Inc. | Director | Current |
| Viewpoint School | Board of Directors | Current |
| Tanox, Inc. | Chief Financial Officer | Former |
| The NutraSweet Company | Chief Financial Officer | Former |
| Amgen Inc. | Chief Accounting Officer | Former |
| Renovis, Inc. | Vice President, Drug Discovery | Former |
| Tanox, Inc. | Vice President, Finance | Former |
| Amgen Inc. | Director of Research | Former |
| Biogen, Inc. | Corporate Controller | Former |
| Burroughs Wellcome Co. - USA | Chemist | Former |
| University of Michigan | MD | Former |
| University of Southampton | Ph.D. In Chemistry | Former |
| University of Nottingham | Former |
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | V.P., Finance and Cao | Current |
John C. Doyle has served as our Senior Vice President, Corporate Development, and Chief Financial Officer since January 2007. He previously served as Senior Vice President, Finance & Operations, and Chief Financial Officer since August 2006 and before that as our Vice President, Finance and Chief Financial Officer since joining Renovis in August 2002. From 1999 to 2002, Mr. Doyle served as Director of Finance and then as Vice President, Venture Finance at Garage Technology Ventures, a venture capital investment bank, where he raised capital for the firm's principal investing activities and managed private placement operations. Prior to joining Garage Technology Ventures, Mr. Doyle was Controller of Tularik Inc., a biotechnology company, from 1996 to 1999. Mr. Doyle managed financial reporting at Athena Neurosciences, Inc., a biotechnology company (acquired by Elan Corporation), during 1996 and was an auditor at Price Waterhouse LLP (now PricewaterhouseCoopers) from 1991 to 1996. Mr. Doyle is a Certified Public Accountant and received a B.S. in Business Administration from California Polytechnic State University, San Luis Obispo and an M.B.A. from the Haas School of Business at the University of California, Berkeley.
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | Senior Vice President, Corporate Development, and Chief Financial Officer | Current |
| Renovis, Inc. | Board of Directors | Current |
| Garage Technology Ventures | Director of Finance | Former |
| Tularik, Inc. | Controller | Former |
| University of California, Berkeley | M.B.A. from the Haas School of Business | Former |
| California Polytechnic State University | B.S. In Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | Vice President, Discovery Res & Chief Discovery Scientist | Current |
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | General Counsel & Senior Vice President, Corp Development | Current |
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | Vice President, Clinical Development | Current |
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | Vice President, Clinical Development | Current |
| Organization | Position | Status |
|---|---|---|
| Gordon and Betty Moore Foundation | President | Current |
| Renovis, Inc. | Co-Founder | Current |
| Alta Partners | Principal | Current |
| Metabolex, Inc. | Chairman of the Board | Current |
| ZymoGenetics, Inc. | Chairman | Current |
| Chimerix, Inc. | Director | Current |
| Chiron | Director | Current |
| Scynexis, Inc. | Board of Directors | Current |
| Alta Partners | Director | Current |
| ZymoGenetics, Inc. | Board of Directors | Current |
| Gordon and Betty Moore Foundation | Member of the Board of Trustees | Current |
| Chemocentryx, Inc. | Board of Directors | Current |
| Corcept Therapeutics Incorporated | Director | Current |
| National Academy of Sciences | Member | Current |
| Chiron | chief executive officer | Former |
| Chiron | president | Former |
| Chiron | Co-Founder | Former |
| University of California, Berkeley | Member Biochemistry Department | Former |
| University of California, San Diego | Fellow | Former |
| University of California | Dean of the School of Public Health | Former |
| Renovis, Inc. | Chairman of the Board of Directors | Former |
| Chiron | Vice Chairman | Former |
| University of Washington | Ph.D. In Biochemistry | Former |
| Stanford University | A.B. In Biology | Former |
| University of California | post-doctoral fellow | Former |
Array
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | Founder of Pharmion | Current |
| Pharmion Corporation | Board of Directors | Current |
| Chroma Therapeutics Ltd | Board of Directors | Current |
| PRA International Inc. | Board of Directors | Current |
| The Perrigo Company | Board of Directors | Current |
| ZymoGenetics, Inc. | Board of Directors | Current |
| Pharmion Corporation | Executive Vice President and Chief Operating Officer | Former |
| AVAX Technologies, Inc. | Senior Vice President, Business Development | Former |
| Renovis, Inc. | Consultant | Former |
| Marion Laboratories | Consultant | Former |
| Hoechst Marion Roussel | Former | |
| Marion Merrell Dow | Former | |
| University of Missouri | Ph.D. | Former |
| Rockhurst University | M.B.A. | Former |
| Benedictine College | B.S. Degree | Former |
| University of Missouri | B.S. In Biology | Former |
| Rockhurst University | B.S. In Biology | Former |
| Pharmion Corporation | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | Co-founder | Current |
| University of Oxford | B.A. in Philosophy and Physiology | Former |
| McGill University | B.Sc. in Physics | Former |
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | Current | |
| Seaside Therapeutics | Board of Directors | Current |
| Stanford University | Director of the Pritzker Laboratory | Former |
| Stanford University | PhD In Neuroscience | Former |
| Harvard University | Undergraduate Degree | Former |
| Organization | Position | Status |
|---|---|---|
| MPM Capital Limited Partnership | Executive Advisor | Current |
| Renovis, Inc. | Current | |
| Hypnion, Inc. | Current | |
| Broad Institute | Current | |
| National Academy of Sciences | Board of Directors | Current |
| Millipore Corporation | Director | Current |
| Alinea Pharmaceuticals, Inc | Board of Directors | Current |
| Aveo Pharmaceuticals, Inc. | Board of Directors | Current |
| Vlst Corp | Board of Directors | Current |
| Alnylam Pharmaceuticals, Inc. | Board of Directors | Current |
| The Bipolar | Board of Directors | Current |
| American Academy of Arts and Sciences | Member | Current |
| National Academy of Sciences | Member | Current |
| Merck Research Labs | President | Former |
| Merck & Co. Inc. | President | Former |
| National Cancer Institute | Chief of the Laboratory | Former |
| Merck & Co. Inc. | Executive Vice President for Science and Technology | Former |
| Virus Inc. | Executive Director | Former |
| Basic Research | Executive Director | Former |
| Clarus Ventures, LLC | Venture Partner | Former |
| The Regents | Lecturer | Former |
| McLean Hospital | Former | |
| Harvard University | M.D. | Former |
| Harvard Medical School | M.D. | Former |
| Harvard College | A.B.in Biochemical Sciences | Former |
| Harvard University | B.A. | Former |
| The National Institute of Mental Health | member | Former |
| Millipore Corporation | member | Former |
| Organization | Position | Status |
|---|---|---|
| Sanarus Medical, Inc. | Managing Director of Alta Partners and Director | Current |
| Alta Partners | Managing Director | Current |
| Renovis, Inc. | Current | |
| Zelos Therapeutics, Inc. | Chairperson | Current |
| Zelos Therapeutics, Inc. | Board of Directors | Former |
| Portola Pharmaceuticals, Inc. | Board of Directors | Current |
| Alta Partners | Director | Current |
| Myocor, Inc. | Board Member | Current |
| Agensys, Inc. | Board of Directors | Current |
| Aerovance, Inc | Board of Directors | Current |
| Robertson, Stephens & Company | General Partner | Former |
| Smith College | M.B.A. | Former |
| Stanford University | Master of Business Administration | Former |
| Smith College | Bachelor of Arts In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Radiant Medical, Inc. | Current | |
| Renovis, Inc. | Current | |
| University of California, San Francisco | Former | |
| Radcliffe College | B.A. in Chemistry and she received a Ph | Former |
| Harvard Medical School | B.A. in Chemistry and she received a Ph | Former |
| Organization | Position | Status |
|---|---|---|
| Renovis, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Trellis Bioscience, Inc | Founder of Easton Capital Investment Group | Current |
| Easton Capital Investment Group | Founder | Current |
| Genetix Pharmaceuticals, Inc | Managing Partner of Easton Capital Investment Group | Current |
| Easton Capital Investment Group | Managing Partner, New York Office | Current |
| Iga Worldwide, Inc. | Managing Partner, Easton Capital | Current |
| YM BioSciences Inc. | Managing Partner, Easton Hunt Capital Partners | Current |
| Presidents Council | Co-Chairman | Current |
| Iga Worldwide, Inc. | Board of Directors | Current |
| The New York City Police Foundation | Board of Directors | Current |
| New Museum of Contemporary Art | Board of Directors | Current |
| Neighborhood Coalition for Shelter, Inc. | Board of Directors | Current |
| Genetix Pharmaceuticals, Inc | Board of Directors | Current |
| Acorda Therapeutics, Inc. | Board of Directors | Current |
| Trellis Bioscience, Inc | Board of Directors | Current |
| Assistive Technology, Inc. | Board of Directors | Current |
| Cardiovascular Systems Inc. | Director | Current |
| Xoft, Inc. | Board of Directors | Current |
| Easton Capital Investment Group | Board of Directors | Current |
| Comverse Technology, Inc. | Board Member | Current |
| Conor Medsystems, Inc. | Board Member | Current |
| Playspan Inc. | Board of Directors | Current |
| Axys Pharmaceuticals | Chief Executive Officer | Former |
| Cold Spring Harbor Laboratory | President's Council | Former |
| E.M. Warburg Pincus & Co. | Managing Director | Former |
| Easton Capital Investment Group | Owner | Current |
| Axys Pharmaceuticals | Chairman | Former |
| Axys Pharmaceuticals | Director | Former |
| YM BioSciences Inc. | Board of Directors | Current |
| U.S. Healthcare, Inc. | Investor | Former |
| Tweed's, Inc. | Investor | Former |
| Yale Law School | Jd Degree | Former |
| Yale College | BA Degree | Former |
| Yale University | B.A. | Former |
| State University of New York at Buffalo | B.A. In History | Former |
| Renovis, Inc. | member | Former |
| Comverse Technology, Inc. | member | Former |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes


